世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Melatonin API Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global melatonin API market is set for dynamic expansion, driven by increasing awareness of sleep health and the widespread use of melatonin in clinical and wellness applications. With a projec... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global melatonin API market is set for dynamic expansion, driven by increasing awareness of sleep health and the widespread use of melatonin in clinical and wellness applications. With a projected valuation of US$ 3 Bn in 2025, the market is expected to soar to US$ 8.5 Bn by 2032, exhibiting a strong CAGR of 16.04% during the forecast period. The growth trajectory is underpinned by rising consumer demand for over-the-counter sleep aids and growing applications of melatonin in pharmaceuticals and nutraceuticals.Market Insights Melatonin is a naturally occurring molecule found in various living organisms, including plants, animals, and microorganisms. It plays a crucial role in regulating biological and physiological cycles, particularly the sleep-wake cycle. The exogenous use of melatonin, particularly through supplements and OTC medications, has surged due to its effectiveness in managing sleep disorders, jet lag, and circadian rhythm disturbances. With its unique amphiphilic structure, melatonin can penetrate all cellular compartments, functioning as a universal antioxidant and contributing to several biological activities including anti-inflammatory, immunostimulant, and anti-cancer effects. Market Drivers One of the key drivers of market growth is the increasing prevalence of sleep-related disorders such as insomnia, especially among aging populations and shift workers. Melatonin’s ability to shorten sleep latency and regulate circadian rhythms has made it a preferred choice over other pharmaceutical sleep aids. Another growth catalyst is the broader clinical recognition of melatonin’s role beyond sleep regulation. Studies have shown its efficacy in oncology, where it is used as an adjuvant therapy for various cancers due to its anti-proliferative and antioxidant properties. Moreover, the growing trend of incorporating melatonin into nutraceutical formulations has opened new commercial avenues for manufacturers. Business Opportunity The shift toward continuous and automated manufacturing processes presents a massive opportunity for melatonin API producers. CDMO (Contract Development and Manufacturing Organizations) partnerships are becoming increasingly important in optimizing production workflows and speeding up time-to-market for new formulations. Additionally, the integration of digital technologies and the Internet of Things (IoT) into API manufacturing is fostering operational efficiency. Companies are investing in smart manufacturing setups to enhance scalability and improve product quality. These developments not only support the rising demand for melatonin but also ensure regulatory compliance across global markets. Challenges Despite the favorable outlook, the industry faces several challenges. High raw material costs, significant capital investment requirements, and the need for advanced equipment and infrastructure limit the entry of new players. The need to maintain cGMP compliance and ensure product quality further adds to production complexities. Moreover, time-consuming processes such as analytical testing and licensing can slow down product development cycles. Regional Analysis The United States dominates the global melatonin API market, primarily due to robust regulatory frameworks and widespread use of OTC supplements. Regulatory guidelines by the FDA ensure that APIs meet high standards of safety and efficacy, promoting market expansion. In Europe, Germany is emerging as a lucrative market due to its innovations in natural melatonin sources. A Munich-based company’s success in producing melatonin-rich milk without prescription has contributed to market expansion, supported by positive clinical outcomes. China is becoming a key player in melatonin API manufacturing, backed by increasing CMO activities and adherence to cGMP practices. The country’s focus on regulatory compliance and API development has significantly bolstered its position in the global market. Key Players Leading companies in the melatonin API space are focused on strategic collaborations, acquisitions, and facility expansions. Key players include: • Merck KGaA • Caesar & Loretz GmbH • EVONIK • Bio-Techne Corp. • Cayman Chemical Company • Spectrum Chemical • LGM Pharma • Flavine Europe GmbH • Ralington Pharma • SimSon Pharma Limited • Santa Cruz Biotechnology • Biosynth • Otto Chemie Pvt. Ltd. • Pharmaffiliates Analytics and Synthetics P. Ltd. • Clearsynth Labs Recent developments include Bio-Techne Corporation’s expansion of a GMP facility and Biosynth Carbosynth’s acquisition of Vivitide, aimed at scaling production and expanding market presence. Market Segmentation By Source • Natural • Synthetic • Bio-Synthetic By Grade • GMP • Non-GMP By Application • Clinical • Research By Region • North America • Latin America • Europe • Asia Pacific • Oceania • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Melatonin API Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2025 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. Porter’s Five Forces Analysis 2.5. COVID-19 Impact Analysis 2.5.1. Supply 2.5.2. Demand 2.6. Impact of Ukraine-Russia Conflict 2.7. Economic Overview 2.7.1. World Economic Projections 2.8. PESTLE Analysis 3. Global Melatonin API Market Outlook, 2019-2032 3.1. Global Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2019-2032 3.1.1. Key Highlights 3.1.1.1. GMP Grade 3.1.1.2. Non-GMP Grade 3.2. Global Melatonin API Market Outlook, by Source, Value (US$ Bn), 2019-2032 3.2.1. Key Highlights 3.2.1.1. Natural 3.2.1.2. Synthetic 3.2.1.3. Bio-Synthetic 3.3. Global Melatonin API Market Outlook, by Application, Value (US$ Bn), 2019-2032 3.3.1. Key Highlights 3.3.1.1. Clinical Use 3.3.1.2. Research Use 3.4. Global Melatonin API Market Outlook, by Region, Value (US$ Bn), 2019-2032 3.4.1. Key Highlights 3.4.1.1. North America 3.4.1.2. Europe 3.4.1.3. Asia Pacific 3.4.1.4. Latin America 3.4.1.5. Middle East & Africa 4. North America Melatonin API Market Outlook, 2019-2032 4.1. North America Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2019-2032 4.1.1. Key Highlights 4.1.1.1. GMP Grade 4.1.1.2. Non-GMP Grade 4.2. North America Melatonin API Market Outlook, by Source, Value (US$ Bn), 2019-2032 4.2.1. Key Highlights 4.2.1.1. Natural 4.2.1.2. Synthetic 4.2.1.3. Bio-Synthetic 4.3. North America Melatonin API Market Outlook, by Application, Value (US$ Bn), 2019-2032 4.3.1. Key Highlights 4.3.1.1. Clinical Use 4.3.1.2. Research Use 4.3.2. BPS Analysis/Market Attractiveness Analysis 4.4. North America Melatonin API Market Outlook, by Country, Value (US$ Bn), 2019-2032 4.4.1. Key Highlights 4.4.1.1. U.S. Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 4.4.1.2. U.S. Melatonin API Market by Source, Value (US$ Bn), 2019-2032 4.4.1.3. U.S. Melatonin API Market by Application, Value (US$ Bn), 2019-2032 4.4.1.4. Canada Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 4.4.1.5. Canada Melatonin API Market by Source, Value (US$ Bn), 2019-2032 4.4.1.6. Canada Melatonin API Market by Application, Value (US$ Bn), 2019-2032 4.4.2. BPS Analysis/Market Attractiveness Analysis 5. Europe Melatonin API Market Outlook, 2019-2032 5.1. Europe Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2019-2032 5.1.1. Key Highlights 5.1.1.1. GMP Grade 5.1.1.2. Non-GMP Grade 5.2. Europe Melatonin API Market Outlook, by Source, Value (US$ Bn), 2019-2032 5.2.1. Key Highlights 5.2.1.1. Natural 5.2.1.2. Synthetic 5.2.1.3. Bio-Synthetic 5.3. Europe Melatonin API Market Outlook, by Application, Value (US$ Bn), 2019-2032 5.3.1. Key Highlights 5.3.1.1. Clinical Use 5.3.1.2. Research Use 5.3.2. BPS Analysis/Market Attractiveness Analysis 5.4. Europe Melatonin API Market Outlook, by Country, Value (US$ Bn), 2019-2032 5.4.1. Key Highlights 5.4.1.1. Germany Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 5.4.1.2. Germany Melatonin API Market by Source, Value (US$ Bn), 2019-2032 5.4.1.3. Germany Melatonin API Market by Application, Value (US$ Bn), 2019-2032 5.4.1.4. U.K. Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 5.4.1.5. U.K. Melatonin API Market by Source, Value (US$ Bn), 2019-2032 5.4.1.6. U.K. Melatonin API Market by Application, Value (US$ Bn), 2019-2032 5.4.1.7. France Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 5.4.1.8. France Melatonin API Market by Source, Value (US$ Bn), 2019-2032 5.4.1.9. France Melatonin API Market by Application, Value (US$ Bn), 2019-2032 5.4.1.10. Italy Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 5.4.1.11. Italy Melatonin API Market by Source, Value (US$ Bn), 2019-2032 5.4.1.12. Italy Melatonin API Market by Application, Value (US$ Bn), 2019-2032 5.4.1.13. Turkey Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 5.4.1.14. Turkey Melatonin API Market by Source, Value (US$ Bn), 2019-2032 5.4.1.15. Turkey Melatonin API Market by Application, Value (US$ Bn), 2019-2032 5.4.1.16. Russia Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 5.4.1.17. Russia Melatonin API Market by Source, Value (US$ Bn), 2019-2032 5.4.1.18. Russia Melatonin API Market by Application, Value (US$ Bn), 2019-2032 5.4.1.19. Rest of Europe Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 5.4.1.20. Rest of Europe Melatonin API Market by Source, Value (US$ Bn), 2019-2032 5.4.1.21. Rest of Europe Melatonin API Market by Application, Value (US$ Bn), 2019-2032 5.4.2. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Melatonin API Market Outlook, 2019-2032 6.1. Asia Pacific Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2019-2032 6.1.1. Key Highlights 6.1.1.1. GMP Grade 6.1.1.2. Non-GMP Grade 6.2. Asia Pacific Melatonin API Market Outlook, by Source, Value (US$ Bn), 2019-2032 6.2.1. Key Highlights 6.2.1.1. Natural 6.2.1.2. Synthetic 6.2.1.3. Bio-Synthetic 6.3. Asia Pacific Melatonin API Market Outlook, by Application, Value (US$ Bn), 2019-2032 6.3.1. Key Highlights 6.3.1.1. Clinical Use 6.3.1.2. Research Use 6.3.2. BPS Analysis/Market Attractiveness Analysis 6.4. Asia Pacific Melatonin API Market Outlook, by Country, Value (US$ Bn), 2019-2032 6.4.1. Key Highlights 6.4.1.1. China Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 6.4.1.2. China Melatonin API Market by Source, Value (US$ Bn), 2019-2032 6.4.1.3. China Melatonin API Market by Application, Value (US$ Bn), 2019-2032 6.4.1.4. Japan Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 6.4.1.5. Japan Melatonin API Market by Source, Value (US$ Bn), 2019-2032 6.4.1.6. Japan Melatonin API Market by Application, Value (US$ Bn), 2019-2032 6.4.1.7. South Korea Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 6.4.1.8. South Korea Melatonin API Market by Source, Value (US$ Bn), 2019-2032 6.4.1.9. South Korea Melatonin API Market by Application, Value (US$ Bn), 2019-2032 6.4.1.10. India Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 6.4.1.11. India Melatonin API Market by Source, Value (US$ Bn), 2019-2032 6.4.1.12. India Melatonin API Market by Application, Value (US$ Bn), 2019-2032 6.4.1.13. Southeast Asia Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 6.4.1.14. Southeast Asia Melatonin API Market by Source, Value (US$ Bn), 2019-2032 6.4.1.15. Southeast Asia Melatonin API Market by Application, Value (US$ Bn), 2019-2032 6.4.1.16. Rest of Asia Pacific Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 6.4.1.17. Rest of Asia Pacific Melatonin API Market by Source, Value (US$ Bn), 2019-2032 6.4.1.18. Rest of Asia Pacific Melatonin API Market by Application, Value (US$ Bn), 2019-2032 6.4.2. BPS Analysis/Market Attractiveness Analysis 7. Latin America Melatonin API Market Outlook, 2019-2032 7.1. Latin America Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2019-2032 7.1.1. Key Highlights 7.1.1.1. GMP Grade 7.1.1.2. Non-GMP Grade 7.2. Latin America Melatonin API Market Outlook, by Source, Value (US$ Bn), 2019-2032 7.2.1.1. Natural 7.2.1.2. Synthetic 7.2.1.3. Bio-Synthetic 7.3. Latin America Melatonin API Market Outlook, by Application, Value (US$ Bn), 2019-2032 7.3.1. Key Highlights 7.3.1.1. Clinical Use 7.3.1.2. Research Use 7.3.2. BPS Analysis/Market Attractiveness Analysis 7.4. Latin America Melatonin API Market Outlook, by Country, Value (US$ Bn), 2019-2032 7.4.1. Key Highlights 7.4.1.1. Brazil Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 7.4.1.2. Brazil Melatonin API Market by Source, Value (US$ Bn), 2019-2032 7.4.1.3. Brazil Melatonin API Market by Application, Value (US$ Bn), 2019-2032 7.4.1.4. Mexico Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 7.4.1.5. Mexico Melatonin API Market by Source, Value (US$ Bn), 2019-2032 7.4.1.6. Mexico Melatonin API Market by Application, Value (US$ Bn), 2019-2032 7.4.1.7. Argentina Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 7.4.1.8. Argentina Melatonin API Market by Source, Value (US$ Bn), 2019-2032 7.4.1.9. Argentina Melatonin API Market by Application, Value (US$ Bn), 2019-2032 7.4.1.10. Rest of Latin America Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 7.4.1.11. Rest of Latin America Melatonin API Market by Source, Value (US$ Bn), 2019-2032 7.4.1.12. Rest of Latin America Melatonin API Market by Application, Value (US$ Bn), 2019-2032 7.4.2. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Melatonin API Market Outlook, 2019-2032 8.1. Middle East & Africa Melatonin API Market Outlook, by Grade, Value (US$ Bn), 2019-2032 8.1.1. Key Highlights 8.1.1.1. GMP Grade 8.1.1.2. Non-GMP Grade 8.2. Middle East & Africa Melatonin API Market Outlook, by Source, Value (US$ Bn), 2019-2032 8.2.1. Key Highlights 8.2.1.1. Natural 8.2.1.2. Synthetic 8.2.1.3. Bio-Synthetic 8.3. Middle East & Africa Melatonin API Market Outlook, by Application, Value (US$ Bn), 2019-2032 8.3.1. Key Highlights 8.3.1.1. Clinical Use 8.3.1.2. Research Use 8.3.2. BPS Analysis/Market Attractiveness Analysis 8.4. Middle East & Africa Melatonin API Market Outlook, by Country, Value (US$ Bn), 2019-2032 8.4.1. Key Highlights 8.4.1.1. GCC Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 8.4.1.2. GCC Melatonin API Market by Source, Value (US$ Bn), 2019-2032 8.4.1.3. GCC Melatonin API Market by Application, Value (US$ Bn), 2019-2032 8.4.1.4. South Africa Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 8.4.1.5. South Africa Melatonin API Market by Source, Value (US$ Bn), 2019-2032 8.4.1.6. South Africa Melatonin API Market by Application, Value (US$ Bn), 2019-2032 8.4.1.7. Egypt Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 8.4.1.8. Egypt Melatonin API Market by Source, Value (US$ Bn), 2019-2032 8.4.1.9. Egypt Melatonin API Market by Application, Value (US$ Bn), 2019-2032 8.4.1.10. Nigeria Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 8.4.1.11. Nigeria Melatonin API Market by Source, Value (US$ Bn), 2019-2032 8.4.1.12. Nigeria Melatonin API Market by Application, Value (US$ Bn), 2019-2032 8.4.1.13. Rest of Middle East & Africa Melatonin API Market by Grade, Value (US$ Bn), 2019-2032 8.4.1.14. Rest of Middle East & Africa Melatonin API Market by Source, Value (US$ Bn), 2019-2032 8.4.1.15. Rest of Middle East & Africa Melatonin API Market by Application, Value (US$ Bn), 2019-2032 8.4.2. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. By End User vs by Source Heat map 9.2. Manufacturer vs by Source Heatmap 9.3. Company Market Share Analysis, 2025 9.4. Competitive Dashboard 9.5. Company Profiles 9.5.1. Merck 9.5.1.1. Company Overview 9.5.1.2. Product Portfolio 9.5.1.3. Financial Overview 9.5.1.4. Business Strategies and Development 9.5.2. Caesar & Loretz GmbH 9.5.2.1. Company Overview 9.5.2.2. Product Portfolio 9.5.2.3. Financial Overview 9.5.2.4. Business Strategies and Development 9.5.3. EVONIK 9.5.3.1. Company Overview 9.5.3.2. Product Portfolio 9.5.3.3. Financial Overview 9.5.3.4. Business Strategies and Development 9.5.4. Cayman Chemical Company (Matreya) 9.5.4.1. Company Overview 9.5.4.2. Product Portfolio 9.5.4.3. Financial Overview 9.5.4.4. Business Strategies and Development 9.5.5. Bio-Techne Corp. 9.5.5.1. Company Overview 9.5.5.2. Product Portfolio 9.5.5.3. Financial Overview 9.5.5.4. Business Strategies and Development 9.5.6. LGM Pharma 9.5.6.1. Company Overview 9.5.6.2. Product Portfolio 9.5.6.3. Financial Overview 9.5.6.4. Business Strategies and Development 9.5.7. Flavine Europe GmbH 9.5.7.1. Company Overview 9.5.7.2. Product Portfolio 9.5.7.3. Financial Overview 9.5.7.4. Business Strategies and Development 9.5.8. Ralington Pharma 9.5.8.1. Company Overview 9.5.8.2. Product Portfolio 9.5.8.3. Financial Overview 9.5.8.4. Business Strategies and Development 9.5.9. SimSon Pharma Limited 9.5.9.1. Company Overview 9.5.9.2. Product Portfolio 9.5.9.3. Financial Overview 9.5.9.4. Business Strategies and Development 9.5.10. Biosynth 9.5.10.1. Company Overview 9.5.10.2. Product Portfolio 9.5.10.3. Financial Overview 9.5.10.4. Business Strategies and Development 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療IT）の最新刊レポート
Fairfield Market Research社の ヘルスケアIT分野 での最新刊レポート
本レポートと同じKEY WORD（api）の最新刊レポートよくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
